Maintenance sessions or alternative treatments like Pico Laser can help sustain results over time
The committee said this decision provided clear guidance on which patients would most benefit from the therapies
Never discontinue GLP-1 medication without consulting your prescriber, as abrupt cessation may affect glycaemic control or weight management progress
For obesity treatment, dose escalation protocols starting at lower doses (e.g., 2 mg) and gradually increasing to maintenance doses (e.g., 4 mg, 8 mg, or 12 mg) have been studied Link below for more detailed information: Product Overview: Retatru/Cagrilintide is a dual-compound research peptide combining Retatru, a novel multi-agonist peptide with activity across GLP-1, GIP, and glucagon pathways, and Cagrilintide, an amylin analog
Studies show that this process impacts the dermal white adipose tissue, a superficial layer crucial for maintaining youthful fullness and healthy skin structure
In this scenario, the medical claim includes both the drug (often a J -code at Medicare) and the administration service